G1 Therapeutics
Triangle
About G1 Therapeutics
G1 Therapeutics, Inc. is a commercial-stage oncology firm focused on the research and marketing of next-generation anticancer treatments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $50K – $100K
- Total funding: $697.4M
- Funding stage: M&A
- Last round: Post-IPO Equity (Nov 2022)
- Ticker: nasdaq:GTHX
- Website: g1therapeutics.com
- Phone: +1 919 213 9835
Industries & Categories
Biotechnology, Developer Platform, Medical, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/g1-therapeutics-89085 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.